Long-term outcomes of laparoscopic gastric sleeve surgery
Official title: Five-year Outcome of Laparoscopic Gastric Sleeve, Resolution of Comorbidities and Risk for Cumulative Nutritional Deficiencies.
Run by Tartu University Hospital · NCT03467581 · Data updated 2026-11-12
This study looks at how people with severe obesity do five years after having laparoscopic gastric sleeve surgery, focusing on their weight loss, health issues related to obesity, and any nutritional problems they might face.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Tartu University Hospital Academic / other |
| Locations | 1 site (Tartu) |
| Status | Recruiting |
| Started | October 8, 2008 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | March 16, 2018 |
| Trial ID | NCT03467581 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals with a BMI greater than 40, or greater than 35 with obesity-related comorbidities.
✕Probably not a fit
Patients who do not meet the criteria for bariatric surgery will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the five-year outcomes of patients who undergo laparoscopic gastric sleeve surgery for morbid obesity at Tartu University Hospital. It follows patients prospectively to assess weight loss, obesity-related comorbidities, and the risk factors for postoperative nutritional deficiencies. Follow-up visits are scheduled at 3 months, 1 year, and 5 years after the surgery to gather comprehensive data on patient progress and health outcomes.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness and safety of laparoscopic gastric sleeve surgery for weight loss and management of obesity-related health issues.
How similar studies have gone: Other studies have shown positive outcomes with similar approaches in evaluating long-term results of bariatric surgeries, indicating that this methodology is supported by existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The criteria for bariatric surgery: BMI of \>40, or \>35 with certain obesity related comorbidities Exclusion Criteria: * Patients who did not fill the inclusion criteria
Where it's running
-
Tartu University Hospital
Tartu, Estonia Recruiting
Study contacts
- Study coordinator: Toomas Sillakivi, Dr, PhD
- Email: toomas.sillakivi@kliinikum.ee
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Efsubaglutide alfa for weight loss after metabolic surgery
This trial will test whether efsubaglutide alfa helps people who remain obese six months after metabolic surgery lose weight and improve obesity-related health problems.
-
Comparing conventional and tailored limb lengths in gastric bypass surgery
This study is testing whether customizing the lengths of certain parts of gastric bypass surgery can help people lose more weight and improve their health compared to standard lengths.
-
Database for studying obesity and metabolic surgery outcomes in China
This study is collecting information from people in China who have obesity and are having weight loss surgery to see how well these surgeries work in the long run.
-
Database for metabolic surgery outcomes at Beijing Friendship Hospital
This study is collecting information from patients who have had metabolic surgery at Beijing Friendship Hospital to see how well it works for treating obesity-related health issues like type 2 diabetes and high blood pressure.
-
Collagen Supplements After Sleeve Gastrectomy
This observational study looks to see if taking collagen-containing supplements after sleeve gastrectomy affects muscle mass, body composition, and body image in adults who had bariatric surgery.
-
Early reinitiation of semaglutide after sleeve gastrectomy in youth
In youths aged 12–18 with severe obesity who had sleeve gastrectomy and were taking semaglutide, this study tests whether restarting semaglutide two weeks after surgery for 24 months leads to better weight and metabolic outcomes than standard care without drugs.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.